FDA Approves Pfizer Menopause Drug

Source: pharmamanufacturing.com

Oct 07, 2013

wsj.com

The U.S. FDA approved Pfizer Inc's menopause drug Duavee, which the drugmaker hopes will reduce hot flashes and prevent postmenopausal Osteoporosis.

DUAVEE is the first and only therapy to pair conjugated estrogens with an estrogen agonist/antagonist. DUAVEE uses bazedoxifene - instead of a progestin - to help protect the uterine lining against hyperplasia that may result from estrogen-alone treatment. Pfizer anticipates that DUAVEE will be available in the U.S. in the first quarter of 2014. Read more

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments